Vegetative symptoms and drug therapy in Dravet syndrome.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032615

Enrollment

100

Registered

2024-08-30

Start date

2024-09-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G40.4

Interventions

Group 1: Patients with Dravet Syndrome, questionnaire survey on clinical characteristics and KIDSREEN-27, Liverpool Adverse Events Profile, EQ-5D

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dravet Syndrome

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Phenotyping of vegetative symptoms	—

Secondary

Measure	Time frame
Current medical therapy	—

Countries

Germany

Contacts

Public ContactAdam Strzelczyk

Goethe-Universität Frankfurt

strzelczyk@med.uni-frankfurt.de+496963017466

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026